Skip to main content
OpenTrials
Completed

NCT Number: NCT00775047

Pharmacist-Administered Injections for Contraception

The purpose of this study is to see if it is a feasible arrangement to have women receive their second and third birth control injection (with Depo-Provera) at a pharmacy compared with receiving it a Planned Parenthood Clinic. Compliance with returning for injections as well as patient satisfaction with the method, providers, and location where injection was received will be assessed and compared between the two sites. The hypothesis is that there will be no difference in return rates for injections at either the pharmacy or the clinic site.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Contraception

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Planned Parenthood of Central North Carolina

Chapel Hill, North Carolina, 27514, United States

About this study

Women who want to use or are currently using Depo-Provera for contraception will be randomized to receive their next two injections either back at the Planned Parenthood clinic or at a local pharmacy where pharmacists are trained to give injections. After each injection, women will be asked to complete a questionnaire to assess their attitudes about the method of birth control, their providers, and the location where they received the injection.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • At least 18 y.o., English speaking/reading, presenting to Planned Parenthood to use Depo Provera (restarting, first use, or continuing use)

Exclusion criteria

  • Under 18 years of age, English illiterate (reading and verbal)

Treatment and study plan

Pharmacist-administered

Other

women will receive their injections at a pharmacy by a clinical pharmacist

Other names: SQ Depo-Provera

clinic-administered injections

Other

women will return for their injections to the clinic where recruitment took place. They will receive one at 3 months and 6 months.

Other names: SQ Depo-Provera

Primary outcomes

  1. Compliance in returning for 3 month and 6 month injections

    Time frame: 3 months and 6 months after first injection

Secondary outcomes

  1. Attitudes about clinical setting

    Time frame: 3 months and 6 months

Sponsors and collaborators

Lead sponsor

University of North Carolina, Chapel Hill

Other

Collaborators

  • Pfizer

Registry information

Official study title

Pharmacist-Administered Injections of Depo-Medroxyprogesterone Acetate for Contraception: A Pilot Randomized Controlled Trial

Acronym: PAD

Important dates

Study start
2006
Primary completion
2007
Study completion
2008
First posted
Oct 17, 2008
Registry last updated
Oct 17, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.